Advertisement

Advertisement

CTMX Stock Latest News

3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts

Market News3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts

CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron

PremiumCompany Announcements

CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron

6d ago

CytomX Therapeutics expands licensing agreement with Regeneron

PremiumThe Fly

CytomX Therapeutics expands licensing agreement with Regeneron

7d ago

5 Healthcare Stocks Set to Join the Russell 3000

PremiumMarket News

5 Healthcare Stocks Set to Join the Russell 3000

14d ago

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

PremiumWeekend Updates

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

18d ago

CytomX Earnings Call: Varseta‑M Drives Long Runway

PremiumCompany AnnouncementsCytomX Earnings Call: Varseta‑M Drives Long Runway

21d ago

CytomX Therapeutics initiated with an Outperform at Wolfe Research

The Fly

CytomX Therapeutics initiated with an Outperform at Wolfe Research

22d ago

CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar

Company Announcements

CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar

25d ago

CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright

PremiumThe Fly

CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright

30d ago

CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability

PremiumCompany Announcements

CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability

1M ago

CytomX Earnings Call Highlights Varseta-M Momentum

PremiumCompany Announcements

CytomX Earnings Call Highlights Varseta-M Momentum

1M ago

CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)

PremiumThe Fly

CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)

1M ago

CytomX Therapeutics participates in a conference call with JPMorgan

PremiumThe FlyCytomX Therapeutics participates in a conference call with JPMorgan

2M ago

CytomX Therapeutics Signals Progress in Varseta-M Trial

Company Announcements

CytomX Therapeutics Signals Progress in Varseta-M Trial

2M ago

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts

Market News

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts

3M ago

CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler

PremiumThe Fly

CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler

3M ago

CytomX Therapeutics Raises $234 Million in Equity Offering

PremiumCompany Announcements

CytomX Therapeutics Raises $234 Million in Equity Offering

3M ago

CytomX Therapeutics price target raised to $16 from $10 at Barclays

PremiumThe Fly

CytomX Therapeutics price target raised to $16 from $10 at Barclays

3M ago

CytomX Therapeutics price target raised to $16 from $8 at Jefferies

PremiumThe Fly

CytomX Therapeutics price target raised to $16 from $8 at Jefferies

3M ago

CytomX Therapeutics price target raised to $15 from $10 at Guggenheim

PremiumThe FlyCytomX Therapeutics price target raised to $15 from $10 at Guggenheim

3M ago

CytomX Therapeutics 45.9M share Secondary priced at $5.30

The Fly

CytomX Therapeutics 45.9M share Secondary priced at $5.30

3M ago

Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK

The Fly

Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >